Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 80

Sort by

Sort Order Select

Journal Articles

Ex vivo drug sensitivity testing in Korean AML patients: Integration of functional and genomic profiles for predicting clinical response and survival

Daehun Kwag, Hyoju Yi, Seunghyeok Ham, Jiyoung Baek, Sesun Park, Seongjun Lee, George Courcoubetis, Byung-Sik Cho, Sungwon Lim, Heeje Kim, Jamin Koo

Blood (2025) 146 (Supplement 1): 939.

https://doi.org/10.1182/blood-2025-939

Published: 2025

Journal Articles

Earlier detection of transplant-associated thrombotic microangiopathy using harmonization criteria: A real-world comparative evaluation with conventional criteria

Seonghan Lee, Byung-Sik Cho, Ka Young Kim, So Yeon Park, Kyoung Il Min, Hohyung Nam, Daehun Kwag, Jung Yeon Lee, Seonggyu Byeon, Gi June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok-Goo Cho, Heeje Kim

Blood (2025) 146 (Supplement 1): 5999.

https://doi.org/10.1182/blood-2025-5999

Published: 2025

Journal Articles

Visualizing systemic light chain amyloidosis with 18f-flutemetamol PET/CT: Correlation with biomarkers and clinical outcome

Sung-Soo Park, Eun Ji Han, Jung Yeon Lee, Joo Hyun O, Mi-Hyang Jung, Jong-Chan Youn, Heeje Kim, Chang-Ki Min

Blood (2025) 146 (Supplement 1): 2575.

https://doi.org/10.1182/blood-2025-2575

Published: 2025

Journal Articles

Prognostic significance of IKZF1 deletion subtypes in ph-negative BCP-ALL: Biallelic-null deletion predicts the worst survival in TP53-wild type patients

Seung-Hwan Lee, Daehun Kwag, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Heeje Kim, Chang-Ki Min, Seok-Goo Cho, Jae-Ho Yoon

Blood (2025) 146 (Supplement 1): 5149.

https://doi.org/10.1182/blood-2025-5149

Published: 2025

Journal Articles

Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

Blood (2025) 146 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2025-1058

Published: 2025

Journal Articles

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Blood (2025) 146 (Supplement 1): 4284.

https://doi.org/10.1182/blood-2025-4284

Published: 2025

Journal Articles

Comparative efficacy of TBI-based vs. non-TBI reduced toxicity conditioning regimens in adult ALL undergoing allogeneic HCT in CR1: Improved outcomes with TBI-based RTC and ATG/ptcy combination

Kyung won Park, Jaehyun Ahn, Daehun Kwag, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Heeje Kim, Chang-Ki Min, Seok-Goo Cho, Jae-Ho Yoon

Blood (2025) 146 (Supplement 1): 4213.

https://doi.org/10.1182/blood-2025-4213

Published: 2025

Journal Articles

Revisiting the role of second allogeneic HCT for post-transplant relapse in acute lymphoblastic leukemia: Comparative outcomes in the era of targeted therapies

Jaehyun Ahn, Daehun Kwag, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Heeje Kim, Chang-Ki Min, Seok-Goo Cho, Jae-Ho Yoon

Blood (2025) 146 (Supplement 1): 1548.

https://doi.org/10.1182/blood-2025-1548

Published: 2025

Journal Articles

Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506

Blood (2025) 146 (Supplement 1): 170.

https://doi.org/10.1182/blood-2025-170

Published: 2025

Journal Articles

Clinical outcomes and prognostic factors in AML patients undergoing second allogeneic hematopoietic stem cell transplantation

Hohyung Nam, Byung-Sik Cho, Hyunyee Rosa Cho, Ka Young Kim, Kyoung Il Min, So Yeon Park, Daehun Kwag, Seonggyu Byeon, Gi-June Min, Jung Yeon Lee, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok-Goo Cho, Heeje Kim

Blood (2025) 146 (Supplement 1): 7707.

https://doi.org/10.1182/blood-2025-7707

Published: 2025

Journal Articles

MRD-guided outcome analysis of ponatinib plus hyper-CVAD versus historical imatinib in ph-positive ALL: Impact of early response and dose-adjusted ponatinib

Kyoung Il Min, Daehun Kwag, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Heeje Kim, Chang-Ki Min, Seok-Goo Cho, Jae-Ho Yoon

Blood (2025) 146 (Supplement 1): 3327.

https://doi.org/10.1182/blood-2025-3327

Published: 2025

Journal Articles

Impact of initial FLT3-ITD mutated clone numbers on clinical outcomes in Acute Myeloid Leukemia

Daehun Kwag, Gi June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok-Goo Cho, Heeje Kim

Blood (2025) 146 (Supplement 1): 1638.

https://doi.org/10.1182/blood-2025-1638

Published: 2025

Journal Articles

Clinical significance of apoe genotypes in older adults with Acute Myeloid Leukemia: Insights from a consecutively treated cohort

Daehun Kwag, Byung-Sik Cho, Gi June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok-Goo Cho, Heeje Kim

Blood (2025) 146 (Supplement 1): 1636.

https://doi.org/10.1182/blood-2025-1636

Published: 2025

Journal Articles

Bleximenib or placebo in combination with standard induction and consolidation therapy followed by maintenance for the treatment of patients with newly diagnosed KMT2A-rearranged or NPM1-mutant Acute Myeloid Leukemia eligible for intensive chemotherapy: A double-blind Phase 3 study (HOVON 181 AML / AMLSG 37-25)

Blood (2025) 146 (Supplement 1): 1654.

https://doi.org/10.1182/blood-2025-1654

Published: 2025

Journal Articles

Outcomes of patients with relapsed/refractory FLT3mut+ Acute Myeloid Leukemia who resumed gilteritinib therapy after HSCT: Post hoc analysis from the ADMIRAL and COMMODORE trials

Mark Levis, Alexander Perl, Jianda Hu, Heeje Kim, Vladimir Ivanov, Hisayuki Yokoyama, Naoko Hosono, Er-Lie Jiang, Dong-Yeop Shin, Bartlomiej Getta, Ashish Bajel, Jamie Jung-Hee An, Dina Elsouda, Juan Ariza, Jianxiang Wang

Blood (2025) 146 (Supplement 1): 42.

https://doi.org/10.1182/blood-2025-42

Published: 2025

Journal Articles

Incidence and Risk Factors for Central Nervous System Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia

Jong Hyuk Lee, Jae-Ho Yoon, Daehun Kwag, Gi-June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Heeje Kim, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Seok Lee

Blood (2023) 142 (Supplement 1): 2210.

https://doi.org/10.1182/blood-2023-181540

Published: 2023

Journal Articles

Correlation between Clinical Diagnosis and Histopathological Findings of Liver Dysfunction after Allogeneic-HSCT

Ka Young Kim, Jung Yeon Lee, Gi June Min, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Heeje Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Jae-Ho Yoon

Blood (2023) 142 (Supplement 1): 6999.

https://doi.org/10.1182/blood-2023-185518

Published: 2023

Journal Articles

Exploring Clonal Hematopoiesis in Chronic Graft Versus Host Disease Patients: A Comprehensive Study

Hongyul An, Silvia Park, Jiwoo Lim, Byoung-Sik Cho, Jong Hyuk Lee, Youngil Koh, Heeje Kim

Blood (2023) 142 (Supplement 1): 1319.

https://doi.org/10.1182/blood-2023-185207

Published: 2023

Journal Articles

Haploidentical Stem Cell Transplantation Using Total Body Irradiation (600 cGy) and Fludarabine with ATG in Upfront and Salvage Setting in Adult Patients with Severe Aplastic Anemia

Sung-Eun Lee, Gi-June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Byoung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Heeje Kim, Seok-Goo Cho, Jong-Wook Lee

Blood (2023) 142 (Supplement 1): 4098.

https://doi.org/10.1182/blood-2023-188758

Published: 2023

Journal Articles

Quantum-First Trial: FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( FLT3 -ITD)-Specific Measurable Residual Disease (MRD) Clearance Assessed through Induction (IND) and Consolidation (CONS) Is Associated with Improved Overall Survival (OS) in Newly Diagnosed (nd) FLT3 -ITD+ AML Patients (pts)

Blood (2023) 142 (Supplement 1): 832.

https://doi.org/10.1182/blood-2023-186785

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Ex vivo drug sensitivity testing in Korean AML patients: Integration of functional and genomic profiles for predicting clinical response and survival

Earlier detection of transplant-associated thrombotic microangiopathy using harmonization criteria: A real-world comparative evaluation with conventional criteria

Visualizing systemic light chain amyloidosis with 18f-flutemetamol PET/CT: Correlation with biomarkers and clinical outcome

Prognostic significance of IKZF1 deletion subtypes in ph-negative BCP-ALL: Biallelic-null deletion predicts the worst survival in TP53-wild type patients

Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Comparative efficacy of TBI-based vs. non-TBI reduced toxicity conditioning regimens in adult ALL undergoing allogeneic HCT in CR1: Improved outcomes with TBI-based RTC and ATG/ptcy combination

Revisiting the role of second allogeneic HCT for post-transplant relapse in acute lymphoblastic leukemia: Comparative outcomes in the era of targeted therapies

Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506

Clinical outcomes and prognostic factors in AML patients undergoing second allogeneic hematopoietic stem cell transplantation

MRD-guided outcome analysis of ponatinib plus hyper-CVAD versus historical imatinib in ph-positive ALL: Impact of early response and dose-adjusted ponatinib

Impact of initial FLT3-ITD mutated clone numbers on clinical outcomes in Acute Myeloid Leukemia

Clinical significance of apoe genotypes in older adults with Acute Myeloid Leukemia: Insights from a consecutively treated cohort

Outcomes of patients with relapsed/refractory FLT3mut+ Acute Myeloid Leukemia who resumed gilteritinib therapy after HSCT: Post hoc analysis from the ADMIRAL and COMMODORE trials

Incidence and Risk Factors for Central Nervous System Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia

Correlation between Clinical Diagnosis and Histopathological Findings of Liver Dysfunction after Allogeneic-HSCT

Exploring Clonal Hematopoiesis in Chronic Graft Versus Host Disease Patients: A Comprehensive Study

Haploidentical Stem Cell Transplantation Using Total Body Irradiation (600 cGy) and Fludarabine with ATG in Upfront and Salvage Setting in Adult Patients with Severe Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only